US 9849100
Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities
granted A61KA61K31/00A61K31/165
Quick answer
US patent 9849100 (Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities) held by KalVista Pharmaceuticals Limited expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/00, A61K31/165, A61K31/166, A61K31/18